Your browser doesn't support javascript.
loading
Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine.
Galldiks, Norbert; Dunkl, Veronika; Ceccon, Garry; Tscherpel, Caroline; Stoffels, Gabriele; Law, Ian; Henriksen, Otto M; Muhic, Aida; Poulsen, Hans S; Steger, Jan; Bauer, Elena K; Lohmann, Philipp; Schmidt, Matthias; Shah, Nadim J; Fink, Gereon R; Langen, Karl-Josef.
Afiliação
  • Galldiks N; Department of Neurology, University Hospital Cologne, Josef-Stelzmann St. 9, 50937, Cologne, Germany. n.galldiks@fz-juelich.de.
  • Dunkl V; Institute of Neuroscience and Medicine (INM-3, -4), Forschungszentrum Juelich, Leo-Brandt-St. 5, 52425, Juelich, Germany. n.galldiks@fz-juelich.de.
  • Ceccon G; Center of Integrated Oncology (CIO), Universities of Cologne and Bonn, Cologne, Germany. n.galldiks@fz-juelich.de.
  • Tscherpel C; Department of Neurology, University Hospital Cologne, Josef-Stelzmann St. 9, 50937, Cologne, Germany.
  • Stoffels G; Department of Neurology, University Hospital Cologne, Josef-Stelzmann St. 9, 50937, Cologne, Germany.
  • Law I; Department of Neurology, University Hospital Cologne, Josef-Stelzmann St. 9, 50937, Cologne, Germany.
  • Henriksen OM; Institute of Neuroscience and Medicine (INM-3, -4), Forschungszentrum Juelich, Leo-Brandt-St. 5, 52425, Juelich, Germany.
  • Muhic A; Institute of Neuroscience and Medicine (INM-3, -4), Forschungszentrum Juelich, Leo-Brandt-St. 5, 52425, Juelich, Germany.
  • Poulsen HS; Department of Clinical Physiology, Nuclear Medicine & PET, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Steger J; Department of Clinical Physiology, Nuclear Medicine & PET, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Bauer EK; Department of Oncology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Lohmann P; Department of Oncology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Schmidt M; Department of Neurology, University Hospital Cologne, Josef-Stelzmann St. 9, 50937, Cologne, Germany.
  • Shah NJ; Department of Neurology, University Hospital Cologne, Josef-Stelzmann St. 9, 50937, Cologne, Germany.
  • Fink GR; Institute of Neuroscience and Medicine (INM-3, -4), Forschungszentrum Juelich, Leo-Brandt-St. 5, 52425, Juelich, Germany.
  • Langen KJ; Dept. of Nuclear Medicine, University Hospital Cologne, Cologne, Germany.
Eur J Nucl Med Mol Imaging ; 45(13): 2377-2386, 2018 12.
Article em En | MEDLINE | ID: mdl-29982845
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tirosina / Imageamento por Ressonância Magnética / Glioblastoma / Tomografia por Emissão de Pósitrons / Bevacizumab / Lomustina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Nucl Med Mol Imaging Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tirosina / Imageamento por Ressonância Magnética / Glioblastoma / Tomografia por Emissão de Pósitrons / Bevacizumab / Lomustina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Nucl Med Mol Imaging Ano de publicação: 2018 Tipo de documento: Article